|
|
|
|
Final-phase trial underway for everolimus in gastric cancer
ORLANDOPretreated patients with metastatic gastric cancer experienced a boost in overall survival after treatment with everolimus (Afinitor), according to the results of a phase II trial presented at the 2010 Gastrointestinal Cancers Symposium.Based on these...
|
|
|
Medical News: Enzon Opens Pediatric Study Of PEG-SN38
Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug ...
|
|
|
Enzon Opens Pediatric Study Of PEG-SN38
Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug ...
|
|
|
Enzon Opens Pediatric Study of PEG-SN38
- Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer...
|
|
|
Enzon Pharmaceuticals initiates treatment in Phase I cancer trial
(Datamonitor via COMTEX) -- Enzon Pharmaceuticals, a biopharmaceutical company, has reported that the first patient has been treated in the Phase I study of PEG-SN38 for pediatric cancer patients.PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the...
|
|
|
Enzon Pharmaceuticals initiates treatment in Phase I cancer trial
Enzon Pharmaceuticals, a biopharmaceutical company, has reported that the first patient has been treated in the Phase I study of PEG-SN38 for pediatric cancer patients.PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the...
|
|
|
Enzon Pharmaceuticals initiates treatment in Phase I cancer trial
Enzon Pharmaceuticals, a biopharmaceutical company, has reported that the first patient has been treated in the Phase I study of PEG-SN38 for pediatric cancer patients.PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the...
|
|
|
Enzon Opens Pediatric Study of PEG-SN38
Enzon Pharmaceuticals, Inc.announced that the first patient has been treated in the Phase 1 study of PEGSN38 for pediatric cancer patients. PEGSN38 or EZN2208 is Enzons PEGylated form of SN38, the active metabolite of the cancer drug Camptosar.
|
|
|
Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients
Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzons PEGylated form of SN38, the active metabolite of the cancer...
|
|
|
Enzon Pharma Treats First Patient In PEG-SN38 Phase 1 study
Enzon Pharmaceuticals (Enzon) has treated first patient in the Phase 1 study of PEG-SN38 for pediatric cancer patients.PEG-SN38 or EZN-2208 is Enzons PEGylated form of SN38, the active metabolite of the cancer drug Camptosar (irinotecan HCl injection)....
|
|
|
Enzon Opens Pediatric Study of PEG-SN38
BRIDGEWATER, N.J.-- (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzons PEGylated form of SN38,...
|
|
|
Enzon Opens Pediatric Study of PEG-SN38
Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzons PEGylated form of SN38, the active metabolite of the cancer...
|
|
|
Enzon Opens Pediatric Study of PEG-SN38
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon?s PEGylated form of SN38,...
|
|
|
Enzon Opens Pediatric Study of PEG-SN38
Companies mentioned in this article: Enzon Pharmaceuticals, Inc.BRIDGEWATER, N.J. -- (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric...
|
|
|
Clinically Speaking: Advanced Laboratory Tests Assist Physicians in Fight Against Colorectal Cancer
Colorectal cancer (CRC) is the second leading cause of cancer-related death for men and women in the United States.Unfortunately, despite well-defined recommendations, compliance with screening protocols remains suboptimal. However, for those patients...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Candidates Etc
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); DUBLIN - (Business Wire) Research and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the "" report to their offering.Until a decade ago...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Candidates Etc
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the "" report to their offering.Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Candidates Etc
DUBLINResearch and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the "" report to their offering.Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but ...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners
Research and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the 'Colorectal Cancer Drug Pipeline Update 2010' report to their offering.Until a decade ago, 5FU/leucovorin formed the mainstay of...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Candidates Etc
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the "Colorectal Cancer Drug Pipeline Update 2010" report to their offering.Until a decade ago, 5FU/leucovorin...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Candidates Etc
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the "Colorectal Cancer Drug Pipeline Update 2010" report to their offering.Until a decade ago, 5FU/leucovorin...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Cand
Research and Markets: - Find Competitors, Collaborations Partners & Candidates Etc DUBLIN - (BUSINESS WIRE) - Research and Markets (http://www.researchandmarkets.com/research/391a9c/colorectal_cancer) has announced the addition of the "" report to their...
|
|
|
Research and Markets: Colorectal Cancer Drug Pipeline Update 2010 - Find Competitors, Collaborations Partners & Candidates etc
Research and Markets (http://www.researchandmarkets.com/research/f23001/colorectal_cancer) has announced the addition of the "Colorectal Cancer Drug Pipeline Update 2010" report to their offering.Until a decade ago, 5FU/leucovorin formed the mainstay of...
|
|
|
Enzon begins phase-2 study of PEG-SN38 for metastatic breast cancer
Enzon Pharmaceuticals, Inc announced that the first patient has been treated in the phase-2 studies of PEG-SN38 for metastatic breast cancer.PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar ...
|
